Identification of Novel Series of Potent and Selective Relaxin Family Peptide Receptor 1 (RXFP1) Agonists

Kenneth L. Granberg,Shigeki Sakamaki,Ryuichi Fuchigami,Yasuki Niwa,Masakazu Fujio,Harutoshi Kato,Fredrik Bergström,Niklas Larsson,Mikael Persson,Inmaculada C. Villar,Takuya Fujita,Emiko Sugikawa,Magnus Althage,Naoko Yano,Yoshito Yokoyama,Junpei Kimura,Mark Lal,Hideki Mochida,Fredrik Bergström
DOI: https://doi.org/10.1021/acs.jmedchem.3c02183
IF: 8.039
2024-03-20
Journal of Medicinal Chemistry
Abstract:Relaxin H2 is a clinically relevant peptide agonist for relaxin family peptide receptor 1 (RXFP1), but a combination of this hormone's short plasma half-life and the need for injectable delivery limits its therapeutic potential. We sought to overcome these limitations through the development of a potent small molecule (SM) RXFP1 agonist. Although two large SM HTS campaigns failed in identifying suitable hit series, we uncovered novel chemical space starting from the only known SM RXFP1 agonist...
chemistry, medicinal
What problem does this paper attempt to address?